The Edinburgh Investment Trust plc Issues Warning From Woodford

The portfolio manager of the Edinburgh Investment Trust plc (LON: EDIN), Neil Woodford, sees lower returns during the next three years.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The shares of Edinburgh Investment Trust (LSE: EDIN) climbed 7p to 585p during early trade this morning despite the FTSE 250 member publishing half-year results that carried a warning from Neil Woodford.

Mr Woodford, who manages the portfolio owned by the Edinburgh trust through investment group Invesco Perpetual, cautioned that “returns over the next three years are likely to be somewhat lower than over the last three years, purely as a consequence of the higher valuations that we now see in our market.

He also claimed the withdrawal of “extraordinary” monetary policies in the US was “ultimately inevitable” and admitted he was worried about “the near-term implications of tapering” for equities.

While Mr Woodford added it was “more difficult than usual” to predict the path that the market could take over the next few months, he did reassure shareholders of the Edinburgh trust that their portfolio had “the potential to deliver an attractive positive return over more sensible, longer-time horizons.”

The trust’s half-year results showed the portfolio’s net assets advancing 2% to 592p per share with debt measured at par value.

Major holdings at the September half-year included Woodford favourites GlaxoSmithKline, AstraZeneca, BT, British American Tobacco and Roche.

Mr Woodford also took the opportunity to criticise recent political remarks about the utility sector.

Referring to the 20-month bill freeze proposed by the Labour Party, he described the economics of the policy as “absurd“.

Mr Woodford claimed:

We believe it is irrational for any privately-owned company to sell its products or services at a loss and we would encourage any company that was forced to do so to simply stop supplying.

Prices have not increased through company profiteering – there have been 20 separate inquiries into the energy market since 2001, none of which have found evidence of anti-competitive behaviour.

The Edinburgh trust has stakes in gas supplier Centrica and electricity generator SSE.

Last month Mr Woodford announced he would leave Invesco Perpetual in April to start his own fund-management business.

Jim Pettigrew, the chairman of the Edinburgh trust, said the board “would like to take some time to consider the options for the future management of the company before it makes a decision“.

Based on this morning’s share-price reaction, Edinburgh’s shares trade at about book value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Maynard does not own any share mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »